Top ten antipsychotic drugs in the U.S. by revenue 2011-2012
This statistic represents the top antipsychotic drugs in the United States, based on revenue between July 2011 and June 2012. In this period, antipsychotic drug Abilify generated some 5.4 billion U.S. dollars of revenues.